Altre lingue Krystal Biotech, Inc.

Azioni

KRYS

US5011471027

Tempo reale stimato Cboe BZX Altri mercati azionari 19:16:43 18/04/2024			Variaz. 5gg	Var. 1 gen.
167,2 ^USD	-1,41%		-6,49%	+35,64%

16/04	KRYSTAL BIOTECH, INC. : Stifel Nicolaus ancora positivo	ZM
12/03	L'insider di Krystal Biotech ha venduto azioni per un valore di 8.547.719 dollari, secondo un recente deposito SEC	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting	05/04
Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting	04/04
Krystal Biotech Insider Sold Shares Worth $8,547,719, According to a Recent SEC Filing	12/03
Krystal Biotech Insider Sold Shares Worth $8,547,719, According to a Recent SEC Filing	12/03
Krystal Biotech to Present at TD Cowen 44th Annual Health Care Conference	29/02
Krystal Biotech to Present at TD Cowen 44th Annual Health Care Conference	28/02
Sector Update: Health Care Stocks Ease Late Afternoon	26/02
Sector Update: Health Care Stocks Weaker Monday Afternoon	26/02
Top Midday Gainers	26/02
Krystal Biotech Shares Jump After Surprise Q4 Profit	26/02
Krystal Biotech Swings to Q4 Profit as Company Generates Revenue; Shares Climb Pre-Bell	26/02
Krystal Biotech, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	26/02
Earnings Flash (KRYS) KRYSTAL BIOTECH Posts Q4 EPS $0.30, vs. Street Est of $-0.25	26/02
Krystal Biotech Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates	26/02
Krystal Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	26/02
North American Morning Briefing : Traders Await Inflation Data This Week	26/02
MORNING BID AMERICAS-Booming stocks step back as PCE hoves into view	26/02
Krystal Biotech to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024	21/02
Krystal Biotech to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024	20/02
Cystic Fibrosis Pipeline Insights Report 2024 \| Krystal Biotech, Vertex Pharmaceuticals, Translate Bio, Novartis, and others.	19/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Krystal Biotech, Inc.

Azioni

KRYS

US5011471027

Altre lingue

Filtri